Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
FACS analysis of APP (GFP) on HEK293/Human APP (GFP) Stable Cell Line.
HEK293/Human APP (GFP) Stable Cell Line was red line, negative control HEK293 cells was grey line (QC tested).
The purity of Human APP Protein, His Tag (Cat. No. APP-H52H3) is more than 85% and the molecular weight of this protein is around 80-110 kDa verified by SEC-MALS.
The purity of Human SAPPbeta, His Tag (Cat. No. APP-H52H5) is more than 90% and the molecular weight of this protein is around 95-115 kDa verified by SEC-MALS.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Florapronol (18F) | 18F-FC-119S; 18F-FC-119(S) | Approved | Korea Institute Of Radiological And Medical Sciences, Futurechem | Alzavue | Alzheimer Disease | Details | ||||
L-Lysine hydrochloride/Cyanocobalamin/Inositol | Approved | 兴邦 | Malnutrition | Details | ||||||
Immune Globulin Subcutaneous (Human) (Octapharma) | Approved | Octapharma | Cutaquig, Octanorm, Gammanorm | United States | Immunologic Deficiency Syndromes | null | 2018-08-02 | Immunologic Deficiency Syndromes | Details | |
Sodium Oligomannurarate | GV-971; 971 | Approved | Ocean University Of China, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | 九期一 | Mainland China | Alzheimer Disease | Shanghai Greenvalley Pharmaceutical Co Ltd | 2019-11-02 | Alzheimer Disease; Parkinson Disease | Details |
Inositol | 4L6452S749 | Approved | Nicosit | Anovulation; Depression; Anxiety; Diabetic Neuropathies; Polycystic Ovary Syndrome; Glucose Intolerance; Insulin Resistance; Infant, Newborn, Diseases; Bronchopulmonary Dysplasia; Metabolic Diseases; Lung Neoplasms; Precancerous Conditions; Retinopathy of Prematurity; Infant, Premature, Diseases; Carcinoma, Non-Small-Cell Lung; Hyperandrogenism | Details | |||||
Immune globulin 10% (Grifols) | KIg-10; TAL-05-0002 | Approved | Bayer AG | Gamunex, Gammaked | United States | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Purpura, Thrombocytopenic, Idiopathic; Immunologic Deficiency Syndromes | null | 2003-08-27 | Postural Orthostatic Tachycardia Syndrome; Anemia, Sickle Cell; Corneal Neovascularization; Kidney Failure, Chronic; Immunologic Deficiency Syndromes; Muscular Diseases; Common Variable Immunodeficiency; Neuralgia; Reflex Sympathetic Dystrophy; Obsessive-Compulsive Disorder; Severe Combined Immunodeficiency; Primary Immunodeficiency Diseases; Anxiety Disorders; Autoimmune Diseases; Coronavirus Disease 2019 (COVID-19); Pain; Agammaglobulinemia; Tibial Fractures; Purpura, Thrombocytopenic, Idiopathic; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Wiskott-Aldrich Syndrome; Myasthenia Gravis | Details |
Flutemetamol (18F) | AH-110690; GE-067; 18F-GE067 | Approved | Ge Healthcare | Vizamyl | Japan | Contrast agents | Nihon Medi-Physics Co Ltd | 2013-10-25 | Atherosclerosis; Cardiomyopathies; Breast Neoplasms; Contrast agents; Cognitive Dysfunction; Alzheimer Disease; Dementia; Diagnostic agents; Hydrocephalus, Normal Pressure; Cognition Disorders | Details |
Florbetapir(18F) | MNI-798; AV-45 | Approved | Eli Lilly And Company | Amyvid | Japan | Diagnostic agents | Eli Lilly And Company | 2012-04-06 | Amyloidosis; Hypersensitivity; Frontotemporal Dementia; Neurodegenerative Diseases; Collagen Diseases; Eye Diseases; Diagnostic agents; Lewy Body Disease; Rheumatic Diseases; Respiration Disorders; Parkinson Disease; Cognitive Dysfunction; Alzheimer Disease; Contrast agents; Spasms, Infantile; Multiple Sclerosis; Skin Diseases | Details |
Aducanumab | BIIB-037; NI-10; BART | Approved | Eisai Co Ltd, Neurimmune Ag | ADUHELM | United States | Alzheimer Disease | Biogen Inc | 2021-06-07 | Alzheimer Disease; Cognitive Dysfunction | Details |
Florbetaben (18F) | MNI-815; AV-1; ZK-6013443; BAY-949172 | Approved | Piramal | Neuraceq | United States | Hyponatremia | Molecular Life Inc | 2014-02-20 | Supranuclear Palsy, Progressive; Down Syndrome; Hyponatremia; Immunoglobulin Light-chain Amyloidosis; Dementia; Alzheimer Disease; Amyloidosis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
[18F]THK-5105 | [18F]THK-5105 | Phase 2 Clinical | Tohoku University | Alzheimer Disease | Details |
RIV-1061-IR | RIV-1061; RIV-1061-IR | Phase 1 Clinical | Revivo Therapeutics | Alzheimer Disease; Cognition Disorders | Details |
11C-BF-227 | 11C-BF-227; [11C]BF-227 | Phase 2 Clinical | Tohoku University | Diagnostic agents | Details |
Abeta42 antibody (Lilly) | Phase 1 Clinical | Eli Lilly And Company | Alzheimer Disease | Details | |
[18F]THK-5117 | [18F]THK-5117 | Phase 2 Clinical | Tohoku University | Alzheimer Disease | Details |
RQ-9 | AAT-009; RQ-9; RQ-00000009 | Phase 1 Clinical | Pfizer Inc | Dementia | Details |
A ß antibody Fab | Phase 1 Clinical | Eli Lilly And Company | Alzheimer Disease | Details | |
PRX-012 | PRX-012 | Phase 1 Clinical | Prothena | Alzheimer Disease | Details |
ASN-120290 | ASN-120290; ASN-561; ASN-90 | Phase 1 Clinical | Merck Serono | Alzheimer Disease | Details |
APH-1105 | APH-1105 | Aphios | Details | ||
Trontinemab | RO-7126209; RG-6102 | F. Hoffmann-La Roche Ltd | Details | ||
E-2212 | GSM-2; GSM-A; E-2212 | Eisai Co Ltd | Details | ||
AD-35 | AD-35 | Phase 2 Clinical | Zhejiang Hisun Pharmaceutical Co Ltd | Alzheimer Disease | Details |
Lu-AF-20513 | Lu-AF-20513 | H. Lundbeck A/S, Otsuka Pharmaceutical Co Ltd | Details | ||
Indole-3-propionic acid | SHP-22; SHP-622; VP-20629; OX-1; IN-OX1 | Intellect Neurosciences | Details | ||
SHR-1707 | SHR-1707 | Phase 1 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd | Alzheimer Disease | Details |
UBITh AD immunotherapeutic vaccine (United Biomedical) | UB-311 | United Biomedical Inc | Details | ||
KHK-6640 | KHK-6640 | Immunas | Details | ||
PPI-1019 | PPI-1019 | Glaxosmithkline Plc | Details | ||
ALZ-101 | ALZ-101 | Phase 1 Clinical | Alzinova AB | Alzheimer Disease | Details |
AAB-003 | AAB-003; PF-5236812; PF-05236812 | Pfizer Pharmaceuticals Ltd (China), Elan Corp | Details | ||
Anatabine citrate | RCP-006 | Clinical | Rock Creek, Roskamp Institute | Alzheimer Disease; Inflammation | Details |
CAD-106 | CAD-106 | Kuros Biosciences, Novartis Pharma Ag | Details | ||
SAR-228810 | SAR-228810 | Sanofi | Details | ||
Aftobetin | ANCA-11 | Cognoptix Inc, University Of California San Diego | Details | ||
MRZ-99030 | EG-030; GAL-101; MRZ-99030 | Tel Aviv University Trust | Details | ||
Crenezumab | R-7412; RG-7412; RO-5490245; MABT-5102-A | Phase 2 Clinical | Ac Immune Sa, Genentech Inc | Alzheimer Disease | Details |
L-clausenamide | Phase 2 Clinical | Guangzhou Nuohao Pharmaceutical Technology Co Ltd, Fuan Pharmaceutical (Group) Co Ltd, Institue Of Materia Medica Chinese Academy Of Medical Science, Qingdao Huanghai Pharmaceutical Co Ltd | Cognitive Dysfunction; Dementia; Memory Disorders | Details | |
18F-92 | 18F-92 | Phase 2 Clinical | First Affiliated Hospital Of Fujian Medical University | Alzheimer Disease | Details |
Edonerpic | T-817 MA | Phase 2 Clinical | Toyama Chemical Co Ltd, Fujifilm Group | Alzheimer Disease; Cognitive Dysfunction; Hepatic Insufficiency | Details |
Inositol/Vitamin B1/Vitamin B2 | Details | ||||
Procaine Hydrochloride/Vitamin B6/Inositol | Details | ||||
Birtamimab | NEOD-001 | Phase 3 Clinical | Prothena | Immunoglobulin Light-chain Amyloidosis; Amyloidosis | Details |
123I-ABC-577 | 123I-ABC-577 | Clinical | Nihon Medi-Physics Co Ltd | Diagnostic agents | Details |
Valiltramiprosate | NRM-8499; ALZ-801; BLU-8499 | Phase 3 Clinical | Alzheon Inc | Alzheimer Disease | Details |
Buntanetap | ANVS-405; ANVS-401 | Phase 3 Clinical | Raptor Pharmaceutical | Down Syndrome; Chronic Traumatic Encephalopathy; Alzheimer Disease; Cognitive Dysfunction; Parkinson Disease; Frontotemporal Dementia | Details |
BEY-2153 | BEY-2153 | Phase 1 Clinical | Beyondbio Inc | Alzheimer Disease | Details |
Tarenflurbil spraygel (MIKA Pharma) | Clinical | Galen Ltd, Mika Pharma Gmbh | Pain; Arthritis, Rheumatoid; Skin Diseases; Inflammation; Dermatitis, Atopic | Details | |
ABvac-40 | ABvac-40 | Phase 2 Clinical | Araclon Biotech Sl | Alzheimer Disease; Cognitive Dysfunction | Details |
PRI-002 | RD-2; PRI-002 | Phase 1 Clinical | Priavoid | Cognitive Dysfunction; Alzheimer Disease | Details |
ALN-APP | Phase 1 Clinical | Sirna Therapeutics Inc | Cerebral Amyloid Angiopathy; Spinocerebellar Degenerations; Alzheimer Disease; Neurodegenerative Diseases | Details | |
Solanezumab | LY-2062430 | Phase 3 Clinical | Eli Lilly And Company | Alzheimer Disease; Dementia; Cognition Disorders | Details |
LY-3372993 | LY-3372993 | Phase 3 Clinical | Eli Lilly And Company | Alzheimer Disease | Details |
ACU-193 | ACU-193; ACU193 | Phase 1 Clinical | Acumen Pharmaceuticals Inc | Alzheimer Disease | Details |
Gantenerumab | MAb-31; R-1450; RG-1450; R-04909832 | Phase 3 Clinical | Chugai Pharmaceutical Co Ltd | Dementia; Alzheimer Disease | Details |
AMDX-2011P | AMDX-2011P; AMDX2011P | Phase 1 Clinical | Amydis Inc | Parkinson Disease; Amyotrophic Lateral Sclerosis | Details |
CT-1812 | CT-1812; SV-119 | Phase 2 Clinical | Cogrx | Alzheimer Disease; Cognitive Dysfunction; Lewy Body Disease | Details |
Pittsburgh Compound B | [11C]PIB; [11C]6-OH-BTA-1; 11C-PIB | Phase 2 Clinical | The University Of Utah, University Of Pittsburgh, Ge Healthcare, Uppsala Universitet | Ovarian Neoplasms; Brain Concussion; Breast Neoplasms; Parkinson Disease; Alzheimer Disease; Alcoholism; Dementia | Details |
This web search service is supported by Google Inc.